During the past decade, Centro de Urologia (CDU) conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 2 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Centro de Urologia (CDU)" are "Prostatic Neoplasms" (3 trials), "Castration-Resistant Prostatic Cancer" (1 trials), "Metastatic Castrate Sensitive Prostate Cancer" (1 trials), "Metastatic Prostate Cancer" (1 trials) and "Overactive Bladder" (1 trials). Many other conditions were trialed in "Centro de Urologia (CDU)" in a lesser frequency.

Most popular intervention types in "Centro de Urologia (CDU)" are "Drug" (6 trials), "Biological" (4 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Prednisone" (4 trials), "Pembrolizumab" (3 trials), "Enzalutamide" (2 trials) and "Niraparib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Centro de Urologia (CDU)" are 7 trials for "Male" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Centro de Urologia (CDU)". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Centro de Urologia (CDU), undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Centro de Urologia (CDU), 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".